CV Information
SHARIFAH EMILIA BINTI TUAN SHARIF PROFESOR MADYA DR. SHARIFAH EMILIA BINTI TUAN SHARIF
Grant's Name,"Project's Title" (Research Period)(Role)[Sponsorship]
1 RESEARCH UNIVERSITY (TOP DOWN), "THE CHARACTERIZATION MDM2 AND CDK4 GENES AMPLIFICATIONS AND ITS SURVIVAL AMONG LIPOSARCOMA PATIENTS" (01.03.2021 - 29.02.2024) (Team Member)
[ USM (RU TOP-DOWN) ] - Source: eR&I
2 BRIDGING GRANT, "EVALUATION OF CLINICOPATHOLOGICAL DATA IN OSTEOSARCOMA PATIENTS WITH POSITIVE EXPRESSION OF RANKL IMMUNOHISTOCHEMISTRY" (15.12.2018 - 14.12.2019) (Principal)
[ UNIVERSITI SAINS MALAYSIA (USM) ] - Source: eR&I
3 SHORT TERM - ACADEMIC STAFF, "THE VALIDITY OF TLE-1 AS AN IMMUNOHISTOCHEMICAL MARKER FOR SYNOVIAL SARCOMA AND ITS ASSOCIATION WITH TRANSLOCATION T(X; 18)" (15.03.2014 - 14.03.2016) (Principal)
[ USM (JANGKA PENDEK) ] - Source: eR&I
4 SHORT TERM - ACADEMIC STAFF, "EXPRESSION OF AMACR (P504S) AND P63 IN DIFFERENTIATING BENIGN MALIGNANT FOCI IN PROSTATIC NEEDLE BIOPSY SPECIMEN" (15.03.2011 - 14.03.2013) (Principal)
[ USM (JANGKA PENDEK) ] - Source: eR&I
5 INCENTIVE GRANT, "PROSTATE CANCER AND ITS MIMICKERS IN ROUTINE PROSTATIC TISSUE BIOPSY IN HOSPITAL UNIVERSITI SAINS MALAYSIA (HUSM); A DIAGNOSIS WHICH COULD BE MISSED" (03.11.2009 - 02.11.2010) (Principal)
[ USM (INSENTIF) ] - Source: eR&I
6 , "THE CHARACTERIZATION OF MDM2 AND CDK4 GENE AMPLIFICATIONS AND ITS SURVIVAL AMONG LIPOSARCOMA PATIENTS" (01.03.2021 - 29.02.2024)
[ RUT TOP DOWN ] - Source: HCMSv3
7 , "SHARIFAH EMILIA BINTI TUAN SHARIF, -, THE UTILITY OF H3K27 TRI-METHYLATION IMMUNOHISTOCHEMISTRY IN DIFFERENTIATING MALIGNANT PERIPHERAL NERVE SHEATH TUMOR (MPNST) AND ITS HISTOLOGIC MIMICKERS, RM3,000.00," (27.04.2017 - 26.04.2018)
[ USAINS ] - Source: HCMSv3
8 , "THE DETERMINATION OF AGREEMENT USING TLE-1 IMMUNOHISTOCHEMISTRY MARKER AND FLUORESCENCE IN SITU HYBRIDIZATION (FISH) IN SYNOVIAL SARCOMA CASES" (10.08.2016 - 10.08.2018)
[ USAINS ] - Source: HCMSv3